ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


  Click here to read this article as a CME activity


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philip A.R. Hayward
Brian F. Buxton
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayward, P. A.R.
Right arrow Articles by Buxton, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayward, P. A.R.
Right arrow Articles by Buxton, B. F.
Related Collections
Right arrow Coronary disease
Right arrowRelated Article

Ann Thorac Surg 2007;84:795-799
© 2007 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Contemporary Coronary Graft Patency: 5-Year Observational Data From a Randomized Trial of Conduits

Philip A.R. Hayward, FRCS, Brian F. Buxton, FRACS*

Department of Cardiac Surgery, Austin Hospital, Heidelberg, Melbourne, Australia

Accepted for publication April 5, 2007.

* Address correspondence to Dr Buxton, Austin Hospital, PO Box 5555, Heidelberg, Melbourne, Victoria, 3084, Australia (Email: brianbuxton{at}ozemail.com.au).

Background: The Radial Artery Patency and Clinical Outcomes (RAPCO) study has enrolled patients into two trials to compare the radial artery with the free right internal thoracic artery (if age <70 years) or with saphenous vein (if age >70 years) when grafted onto the largest target other than the left anterior descending artery. Patency outcomes in RAPCO will focus only on the trial graft in each case. However, postoperative angiography from this ongoing study has reassessed all coronary grafts, both trial and nontrial: together these offer a valuable observational overview of likely graft patency in the current era in predominately asymptomatic patients, in contrast to symptom-directed studies that may overestimate the incidence of graft failure.

Methods: Protocol-directed percutaneous angiography has been performed at intervals weighted toward the end of the study period, or earlier when directed by symptoms. To date, 184 patients have been studied as per protocol, at time points up to 10 years (mean, 3.9), among whom there are 430 nontrial grafts in addition to the 184 trial grafts. Supplementary angiography (percutaneous or computed tomography) was offered at a fixed 5-year time point postoperatively: at this juncture, 193 trial grafts and 469 nontrial grafts have been imaged. Three masked investigators report grafts as angiographically successful if patent from proximal to distal anastomosis inclusive. Failed grafts include greater than 80% stenosis, string sign, or occlusion.

Results: In staggered protocol-directed angiography, overall patency of the in-situ internal thoracic artery grafts and free arterial grafts was 95.5% (210 of 220) and 91.4%% (150 of 164), respectively, which did not differ significantly (p = 0.13). Saphenous vein graft patency was 83.0% (191 of 230) with a trend to higher failure rate compared with free arterial grafts (p = 0.07), and was significantly lower than that of in-situ internal thoracic artery grafts (p = 0.01). At the optional 5-year time point, outcomes are similar to the protocol-directed findings, with patency of in-situ left and right internal thoracic artery grafts of 95.8% (204 of 213), which was significantly greater than that of the other two groups (p = 0.02 and p < 0.001). Patency of free arterial conduits and saphenous vein grafts was 89.1% (139 of 156) and 82.4% (201 of 244), respectively, which did not differ significantly (p = 0.09) at 5 years.

Conclusions: Although trending to superior patency compared with vein grafts, free arterial conduits have not matched the gold standard achieved by in-situ internal thoracic arteries at trial midpoint. Until the results from RAPCO are available, which will test types of free arterial graft against each other and will compare radial and vein grafts in the longer term, these observational data justify for now our current practice of maximal use of in-situ conduits supplemented by free radial grafts.


Related Article

Invited commentary
Mario Gaudino and Gianfederico Possati
Ann. Thorac. Surg. 2007 84: 799-800. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J.-J. Goy, U. Kaufmann, M. Hurni, S. Cook, F. Versaci, P. Ruchat, O. Bertel, M. Pieper, B. Meier, L. Chiarello, et al.
10-Year Follow-Up of a Prospective Randomized Trial Comparing Bare-Metal Stenting With Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis: The SIMA (Stenting versus Internal Mammary Artery grafting) Trial
J. Am. Coll. Cardiol., September 2, 2008; 52(10): 815 - 817.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Attaran, L. John, and A. El-Gamel
Clinical and Potential Use of Pharmacological Agents to Reduce Radial Artery Spasm in Coronary Artery Surgery
Ann. Thorac. Surg., April 1, 2008; 85(4): 1483 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Gaudino and G. Possati
Invited commentary
Ann. Thorac. Surg., September 1, 2007; 84(3): 799 - 800.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.